Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Taha Al-Shaikhly

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Internal Medicine Journal|August 7, 2023
Proton pump inhibitors and the risk of acquiring a penicillin allergy labelSarah Al-Obaydi, Catherine A Popadiuk, Taha Al-Shaikhly
The Journal of Allergy and Clinical Immunology. in Practice|October 1, 2022
Penicillin Allergy Label Is Associated With Worse Clinical Outcomes in Bacterial PneumoniaLauren W Kaminsky, Aria Ghahramani, Rezhan Hussein, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 19, 2025
Should We Consider Venom Immunotherapy When Levels of Specific IgE to Insect Venom Are Between 0.1 and 0.34?Taha Al-Shaikhly, David B K Golden, Timothy J Craig
The Journal of Allergy and Clinical Immunology. in Practice|July 22, 2021
Penicillin Allergy Label Increases Risk of Worse Clinical Outcomes in COVID-19Lauren W Kaminsky, Shannon Dalessio, Taha Al-Shaikhly, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|June 27, 2021
Use of omalizumab for management of idiopathic anaphylaxis: A systematic review and retrospective case seriesLauren W Kaminsky, Kestutis Aukstuolis, Daniel H Petroni, et al.
Allergy and Asthma Proceedings|November 9, 2024
COVID-19 and severe cutaneous allergic reactions to sulfonamidesElen Deng, Timothy J Craig, Dinh V Nguyen, et al.
Pulmonary Therapy|May 23, 2024
Impact of Sulfonamide Allergy Label on Clinical Outcomes in Patients with Pneumocystis jirovecii PneumoniaShane Stone, Maria P Henao, Timothy J Craig, et al.
Pediatric Rheumatology Online Journal|September 25, 2020
Bacterial infections in a pediatric cohort of primary and acquired complement deficienciesTaha Al-Shaikhly, Kristen Hayward, Matthew L Basiaga, et al.
The Journal of Allergy and Clinical Immunology. Global|July 29, 2024
Tolerability and outcomes with rollout of tixagevimab-cilgavimab in patients with common variable immunodeficiencyDaniela Dluzynski, Taha Al-Shaikhly, Catharine I Paules, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|August 13, 2024
Sulfonamide allergy label and the risk of opportunistic infections in solid organ transplant recipients - A retrospective matched cohort studyTaha Al-Shaikhly, Sarah Al-Obaydi, Timothy J Craig, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Internal Medicine Journal|August 7, 2023
Proton pump inhibitors and the risk of acquiring a penicillin allergy labelSarah Al-Obaydi, Catherine A Popadiuk, Taha Al-Shaikhly
The Journal of Allergy and Clinical Immunology. in Practice|October 1, 2022
Penicillin Allergy Label Is Associated With Worse Clinical Outcomes in Bacterial PneumoniaLauren W Kaminsky, Aria Ghahramani, Rezhan Hussein, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 19, 2025
Should We Consider Venom Immunotherapy When Levels of Specific IgE to Insect Venom Are Between 0.1 and 0.34?Taha Al-Shaikhly, David B K Golden, Timothy J Craig
The Journal of Allergy and Clinical Immunology. in Practice|July 22, 2021
Penicillin Allergy Label Increases Risk of Worse Clinical Outcomes in COVID-19Lauren W Kaminsky, Shannon Dalessio, Taha Al-Shaikhly, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|June 27, 2021
Use of omalizumab for management of idiopathic anaphylaxis: A systematic review and retrospective case seriesLauren W Kaminsky, Kestutis Aukstuolis, Daniel H Petroni, et al.
Allergy and Asthma Proceedings|November 9, 2024
COVID-19 and severe cutaneous allergic reactions to sulfonamidesElen Deng, Timothy J Craig, Dinh V Nguyen, et al.
Pulmonary Therapy|May 23, 2024
Impact of Sulfonamide Allergy Label on Clinical Outcomes in Patients with Pneumocystis jirovecii PneumoniaShane Stone, Maria P Henao, Timothy J Craig, et al.
Pediatric Rheumatology Online Journal|September 25, 2020
Bacterial infections in a pediatric cohort of primary and acquired complement deficienciesTaha Al-Shaikhly, Kristen Hayward, Matthew L Basiaga, et al.
The Journal of Allergy and Clinical Immunology. Global|July 29, 2024
Tolerability and outcomes with rollout of tixagevimab-cilgavimab in patients with common variable immunodeficiencyDaniela Dluzynski, Taha Al-Shaikhly, Catharine I Paules, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|August 13, 2024
Sulfonamide allergy label and the risk of opportunistic infections in solid organ transplant recipients - A retrospective matched cohort studyTaha Al-Shaikhly, Sarah Al-Obaydi, Timothy J Craig, et al.
Pageof 4